High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI. (Q42999970)

From Wikidata

Jump to navigation Jump to search

scientific article published on 4 May 2006

Language	Label	Description	Also known as
English	High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI.	scientific article published on 4 May 2006

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16675450%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16675450%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16675450%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Dimitri Lavillette

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16675450%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16675450%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Philippe Mangeot

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16675450%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Ralf Bartenschlager

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16675450%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

François-Loic Cosset

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16675450%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Cécile Voisset

4

object named as

Cécile Voisset

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16675450%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Thomas Pietschmann

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16675450%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Christelle Granier

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16675450%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Sylvie Ricard-Blum

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16675450%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Zhenyong Keck

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16675450%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Steven Foung

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16675450%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Ngoc Vu-Dac

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16675450%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

0 references

publication date

4 May 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16675450%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Journal of Biological Chemistry

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16675450%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

281

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16675450%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

18285-18295

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16675450%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

27

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16675450%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Binding of hepatitis C virus to CD81

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

CLA-1 is an 85-kD plasma membrane glycoprotein that acts as a high-affinity receptor for both native (HDL, LDL, and VLDL) and modified (OxLDL and AcLDL) lipoproteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Cell entry of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Complete replication of hepatitis C virus in cell culture

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Robust hepatitis C virus infection in vitro

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Adaptive immune responses in acute and chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Neutralizing antibody response during acute and chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Density analysis of hepatitis C virus particle population in the circulation of infected hosts: implications for virus neutralization or persistence

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density Gradients

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Visualization of hepatitis C virions and putative defective interfering particles isolated from low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Analysis of a Highly Flexible Conformational Immunogenic Domain A in Hepatitis C Virus E2

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Viral and Cellular Determinants of Hepatitis C Virus RNA Replication in Cell Culture

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Cross-inhibition of SR-BI- and ABCA1-mediated cholesterol transport by the small molecules BLT-4 and glyburide

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Characterization of functional hepatitis C virus envelope glycoproteins.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Activation of membrane fusion by murine leukemia viruses is controlled in cis or in trans by interactions between the receptor-binding domain and a conserved disulfide loop of the carboxy terminus of the surface glycoprotein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Interaction properties of the procollagen C-proteinase enhancer protein shed light on the mechanism of stimulation of BMP-1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Human monoclonal antibody to hepatitis C virus E1 glycoprotein that blocks virus attachment and viral infectivity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by ApoB-containing lipoproteins.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Hepatitis C virus: buoyant density of the factor VIII-derived isolate in sucrose

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Binding of human lipoproteins (low, very low, high density lipoproteins) to recombinant envelope proteins of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Hepatitis C virus ultrastructure and morphogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Antibodies, viruses and vaccines

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

CD81 is an entry coreceptor for hepatitis C virus

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

CD81 is required for hepatitis C virus glycoprotein-mediated viral infection

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

SR-BI-mediated high density lipoprotein (HDL) endocytosis leads to HDL resecretion facilitating cholesterol efflux.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Scavenger receptor BI (SR-BI) clustered on microvillar extensions suggests that this plasma membrane domain is a way station for cholesterol trafficking between cells and high-density lipoprotein.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Measurement of cholesterol bidirectional flux between cells and lipoproteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

A physical and functional link between cholesterol and tetraspanins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Conservation of the Conformation and Positive Charges of Hepatitis C Virus E2 Envelope Glycoprotein Hypervariable Region 1 Points to a Role in Cell Attachment

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Mimotopes of the hepatitis C virus hypervariable region 1, but not the natural sequences, induce cross-reactive antibody response by genetic immunization

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Proteomics computational analyses suggest that hepatitis C virus E1 and pestivirus E2 envelope glycoproteins are truncated class II fusion proteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Incomplete humoral immunity against hepatitis C virus is linked with distinct recognition of putative multiple receptors by E2 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Acute hepatitis C

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602706200

21 January 2018

Identifiers

10.1074/JBC.M602706200

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16675450%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16675450%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42999970&oldid=1786745957"